Herbion Expectorant Lierre (Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M))

Herbion Expectorant Lierre is traditionally used to aid the removal of mucus in various respiratory conditions.

• Facilitates the mobilization and expectoration of thickened bronchial secretions during episodes of acute bronchitis.
• May reduce the frequency and intensity of cough linked to the common cold by promoting mucus clearance.
• Employed as an adjunctive measure in chronic obstructive pulmonary disease (COPD) to assist patients with chronic mucus retention.
• Can be incorporated in the management of seasonal allergic rhinitis when post‑nasal drip contributes to throat irritation.
• Provides mild soothing of throat discomfort that results from excessive phlegm accumulation.

• The dry extract of Hederae folium contains saponins and flavonoids that stimulate bronchial secretions, increase ciliary activity, and exert a mild mucolytic effect, thereby facilitating the loosening and expulsion of mucus. Additionally, the extract may exert a mild relaxant effect on airway smooth muscle through calcium‑channel modulation, contributing to improved airflow during expectoration.

Adverse reactions reported with oral ivy leaf extracts are generally mild, but rare serious events have been described.

Common

• Mild gastrointestinal discomfort such as nausea, stomach upset, or loose stools.
• Transient taste disturbance or a bitter aftertaste that resolves without treatment.
• Mild skin reactions including rash, pruritus, or erythema at the oral mucosa.
• Slight headache or dizziness that is short‑lasting.

Serious

• Allergic anaphylactic reactions characterized by swelling, urticaria, or difficulty breathing.
• Severe bronchospasm or worsening of asthma symptoms in susceptible persons.
• Signs of hepatotoxicity, including jaundice, dark urine, or elevated liver enzymes.
• Unexplained hypotension or cardiovascular collapse in rare cases.

When considering Herbion Expectorant Lierre, certain precautionary measures should be observed to ensure safe use.

• Avoid use in individuals with known hypersensitivity to ivy (Hedera helix) or related plants.
• Use cautiously in patients with asthma, as bronchoconstriction may occur.
• Do not exceed the recommended daily amount; prolonged high‑dose use lacks safety data.
• Pregnant or breastfeeding women should consult a healthcare professional before use.
• Patients with liver disease should be monitored for potential hepatic effects.
• Children under 12 years of age should not use the product unless advised by a clinician.

Herbion Expectorant Lierre may interact with certain medications; awareness of these interactions helps prevent adverse outcomes.

Avoid

• Concurrent use with other oral expectorants or mucolytics, which may increase the risk of gastrointestinal irritation.
• Combination with monoamine oxidase inhibitors (MAOIs) or serotonergic agents, due to limited safety data.

Use with caution

• Co‑administration with antihistamines or bronchodilators; monitor respiratory response.
• When taken with anticoagulant or antiplatelet drugs; observe for any unexpected bleeding.
• Use alongside herbal supplements containing similar constituents (e.g., other ivy extracts), adjusting dosage to avoid excess exposure.
• Patients on liver‑metabolized drugs should be observed for altered metabolism.